LH/HCG as a monthly injectable contraceptive?
نویسندگان
چکیده
منابع مشابه
Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.
This paper presents data from the first large US clinical trial of Lunelle monthly contraceptive injection, which is a combination of 25 mg of medroxyprogesterone acetate (MPA) and 5 mg of estradiol cypionate (E2C). The lead article reports that there was no occurrence of unintended pregnancies and no contraceptive discontinuation among more than 700 women using the MPA/E2C in a 60-week clinic...
متن کاملRISUG: An intravasal injectable male contraceptive
Over the last two decades RISUG has been drawing attention in the field of male contraception. It promises to sterile men for a period of up to 10-15 years. According to recent studies in animal models, it proves to be completely reversible. Practically, there are no better options available that can assure complete sterility and precise reversibility. Regardless of so much of information avail...
متن کاملFactors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran
Background & aim: The developing countries have the contraceptive prevalence rate of 43%. Contraceptive discontinuation accounts for a large number of unintended pregnancies in these countries. The present study aimed to investigate the factors associated with Cyclofem discontinuation. Methods: This historical cohort study was conducted on 198 females, selected through cluster and Poisson sampl...
متن کاملNorethisterone oenanthate as an injectable contraceptive: use of a modified dose schedule.
Norethisterone oenanthate (NET-OEN) was given as an injectable contraceptive to 295 healthy women over 1606 woman-months. A modified injection schedule was used. There were no pregnancies, and the 12-month, life-table, use-related discontinuation rate was 39.1/100 users. Menstrual disturbance (10.8/100 women), minor side effects (13.5/100 women), and personal reasons (12.0/100 women) were the m...
متن کاملA multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.
BACKGROUND The combination of etonogestrel implants with injectable testosterone decanoate was investigated as a potential male contraceptive. METHODS One hundred and thirty subjects were randomly assigned to three treatment groups, all receiving two etonogestrel rods (204 mg etonogestrel) and 400 mg testosterone decanoate either every 4 weeks (group I, n = 42), or every 6 weeks (group II, n ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Reproduction
سال: 2004
ISSN: 1460-2350
DOI: 10.1093/humrep/deh191